Skip to content
Advertisement

FILE - In this Friday, April 23, 2021 file photo, European Commission President Ursula von der Leyen makes a statement during an official visit to the Pfizer pharmaceutical company in Puurs, Belgium. The European Union has cemented its support for Pfizer-BioNTech and its novel COVID-19 vaccine technology by agreeing to a massive contract extension for a potential 1.8 billion doses through 2023. EU Commission President Ursula von der Leyen tweeted that her office “has just approved a contract for a guaranteed 900 million doses (+900 million options).”  (John Thys, Pool via AP, File)

FILE - In this Friday, April 23, 2021 file photo, European Commission President Ursula von der Leyen makes a statement during an official visit to the Pfizer pharmaceutical company in Puurs, Belgium. The European Union has cemented its support for Pfizer-BioNTech and its novel COVID-19 vaccine technology by agreeing to a massive contract extension for a potential 1.8 billion doses through 2023. EU Commission President Ursula von der Leyen tweeted that her office “has just approved a contract for a guaranteed 900 million doses (+900 million options).” (John Thys, Pool via AP, File)

Featured Photo Galleries